Pulmonx Corporation (LUNG)
NASDAQ: LUNG
· Real-Time Price · USD
3.16
0.19 (6.40%)
At close: Jun 06, 2025, 3:59 PM
3.17
0.32%
After-hours: Jun 06, 2025, 04:04 PM EDT
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Asia Pacific Revenue | 4.44M | 3.02M | 2.87M | 3.41M | 2.69M |
| Asia Pacific Revenue Growth | +46.84% | +5.48% | -16.05% | +27.06% | n/a |
| Emea Revenue | 22.33M | 19.34M | 18.15M | 19.88M | 13.81M |
| Emea Revenue Growth | +15.48% | +6.51% | -8.70% | +44.00% | n/a |
| Other International Geographical Areas Revenue | 556K | 399K | 155K | 128K | 49K |
| Other International Geographical Areas Revenue Growth | +39.35% | +157.42% | +21.09% | +161.22% | n/a |
| United States Revenue | 56.47M | 45.92M | 32.49M | 24.99M | 16.19M |
| United States Revenue Growth | +22.97% | +41.34% | +29.99% | +54.37% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 26.15M | 27.11M | 25.41M | 25.31M | 24.3M | 24.32M | 23.98M | 23.46M | 22.74M | 21.91M | 19.72M | 21.23M | 20.25M | 18.91M | 16.69M | 17.62M | 15.6M | 13.96M | 10.81M | 11.11M | 10.19M | 10.02M | 8.62M | 8.36M | 7.78M |
| Selling, General, and Administrative Revenue Growth | -3.53% | +6.67% | +0.38% | +4.16% | -0.08% | +1.41% | +2.22% | +3.20% | +3.78% | +11.11% | -7.15% | +4.89% | +7.07% | +13.32% | -5.30% | +12.92% | +11.78% | +29.10% | -2.69% | +9.06% | +1.65% | +16.27% | +3.16% | +7.43% | n/a |
| Research and Development Revenue | 4.76M | 5.72M | 3.74M | 3.9M | 4.21M | 3.9M | 4.22M | 5.71M | 4.25M | 3.9M | 4.37M | 3.59M | 3.53M | 3.71M | 2.81M | 3.51M | 3.03M | 2.47M | 2M | 1.43M | 1.56M | 1.6M | 1.4M | 1.45M | 1.52M |
| Research and Development Revenue Growth | -16.82% | +52.72% | -3.95% | -7.41% | +8.06% | -7.68% | -26.09% | +34.26% | +8.97% | -10.60% | +21.48% | +1.70% | -4.69% | +31.72% | -19.71% | +15.56% | +22.73% | +23.79% | +40.04% | -8.88% | -2.37% | +14.58% | -3.65% | -4.69% | n/a |